| A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis (NCT06116565) | Keymed Biosciences Co.Ltd | 2023-12-21 |
| Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma (NCT06151847) | University of Kansas Medical Center | 2023-12-21 |
| Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma (NCT06107738) | Barbara Ann Karmanos Cancer Institute | 2023-12-21 |
| Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors (NCT05280314) | IO Biotech | 2023-12-21 |
| Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis (NCT06104618) | Mayo Clinic | 2023-12-21 |
| FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma (NCT06172595) | Singapore General Hospital | 2023-12-21 |
| AMX0035 and Progressive Supranuclear Palsy (NCT06122662) | Amylyx Pharmaceuticals Inc. | 2023-12-21 |
| Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula (NCT04884256) | Cloudbreak Therapeutics, LLC | 2023-12-21 |
| Role of Intravenous Dexmedetomidine in Reducing Shivering After Shivering Cesarean Section Due to Spinal Anesthesia (NCT06711913) | Liaquat National Hospital & Medical College | 2023-12-21 |
| Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury (NCT05970575) | Neurological Associates of West Los Angeles | 2023-12-21 |
| Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma (NCT05572229) | University Hospital, Lille | 2023-12-21 |
| Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies (NCT05935202) | EuroBloodNet Association | 2023-12-21 |
| A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1 (NCT06061081) | ViiV Healthcare | 2023-12-21 |
| Vasopressor Impact on Brain Circulation, Organ Blood Flow and Tissue Oxygenation During Anesthesia (NCT06083948) | University of Aarhus | 2023-12-20 |
| Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT06180889) | Suzhou Alphamab Co., Ltd. | 2023-12-20 |
| Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC (NCT05718323) | ETOP IBCSG Partners Foundation | 2023-12-20 |
| Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma (NCT07529613) | National Cancer Center Hospital East | 2023-12-20 |
| Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees (NCT05656924) | Spaulding Rehabilitation Hospital | 2023-12-20 |
| Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer (NCT06234748) | University of Michigan Rogel Cancer Center | 2023-12-20 |
| A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes (NCT06021158) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2023-12-20 |
| A Study of LM-24C5 For Advanced Solid Tumors (NCT06187402) | LaNova Medicines Limited | 2023-12-20 |
| Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC (NCT06100705) | Yale University | 2023-12-20 |
| Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients (NCT05914857) | Yangjin | 2023-12-20 |
| Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery (NCT06096181) | Cedars-Sinai Medical Center | 2023-12-20 |
| RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy (NCT06154252) | Cabaletta Bio | 2023-12-20 |
| Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer (NCT06176885) | yue junhan | 2023-12-20 |
| Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction (NCT06017609) | Akros Pharma Inc. | 2023-12-20 |
| Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) (NCT05931393) | University of Texas Southwestern Medical Center | 2023-12-20 |
| A Phase 2 Clinical Study of CU-20401 (NCT06194188) | Cutia Therapeutics（Wuxi）Co.,Ltd | 2023-12-20 |
| Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents (NCT05953389) | Bioprojet | 2023-12-20 |
| MgSO4 as Adjuvants to Bupivacaine vs Neostigmine in TAP Block in Cesarean Section (NCT06513013) | Assiut University | 2023-12-20 |
| Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer (NCT06167694) | Shandong Suncadia Medicine Co., Ltd. | 2023-12-20 |
| Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis (NCT06046222) | NS Pharma, Inc. | 2023-12-20 |
| Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer (NCT06109402) | Shanghai Pulmonary Hospital, Shanghai, China | 2023-12-20 |
| A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults (NCT06182124) | Pfizer | 2023-12-20 |
| Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma (NCT06118086) | Remix Therapeutics | 2023-12-20 |
| CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency (NCT06183736) | Convalife (Shanghai) Co., Ltd. | 2023-12-20 |
| A Trial of HRS-5965 Tablets in Primary IgA Nephropathy (NCT06137768) | Chengdu Suncadia Medicine Co., Ltd. | 2023-12-19 |
| Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) (NCT05859776) | AsclepiX Therapeutics, Inc. | 2023-12-19 |
| Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer (NCT05955170) | Institut Curie | 2023-12-19 |
| Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery (NCT06168799) | AM-Pharma | 2023-12-19 |
| A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment (NCT05828511) | Regeneron Pharmaceuticals | 2023-12-19 |
| Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer (NCT05999812) | University of Texas Southwestern Medical Center | 2023-12-19 |
| EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers (NCT06223659) | Ohio State University Comprehensive Cancer Center | 2023-12-19 |
| Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia (NCT06176235) | Peking University People's Hospital | 2023-12-19 |
| Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer (NCT05933980) | Sun Yat-sen University | 2023-12-19 |
| Metyrapone for Mild Autonomous Cortisol Secretion (MACS) (NCT06106295) | Mayo Clinic | 2023-12-19 |
| Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma (NCT06016920) | Nykode Therapeutics ASA | 2023-12-19 |
| A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants (NCT06151535) | AbbVie | 2023-12-19 |
| Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC (NCT06153368) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-19 |
| UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX) (NCT06129175) | Cytopeutics Sdn. Bhd. | 2023-12-19 |
| Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications (NCT06121271) | University College, London | 2023-12-18 |
| Full-Spectrum Cannabidiol Oil for Anxiety and Depressive Symptoms in Parkinson's Disease (NCT07651930) | Medical University of Warsaw | 2023-12-18 |
| Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention) (NCT06672887) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-12-18 |
| HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer (NCT06014190) | Hansoh BioMedical R&D Company | 2023-12-18 |
| ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors (NCT06007729) | Hansoh BioMedical R&D Company | 2023-12-18 |
| Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease (NCT05800275) | UNICANCER | 2023-12-18 |
| Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer (NCT06187506) | Fudan University | 2023-12-18 |
| Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder (NCT05637879) | White River Junction Veterans Affairs Medical Center | 2023-12-18 |
| A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps (NCT06164704) | Upstream Bio Inc. | 2023-12-18 |
| Life's End Benefits of cannaBidiol and tetrahYdrocannabinol (NCT05644262) | University of Southern California | 2023-12-18 |
| A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years (NCT06106581) | Valneva Austria GmbH | 2023-12-18 |
| DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers (NCT05770037) | Cancer Research UK | 2023-12-18 |
| BLOCK-SAH - PPF-Block for Post-SAH Headache (NCT06008795) | University of Florida | 2023-12-17 |
| The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study (NCT04700527) | UNC Lineberger Comprehensive Cancer Center | 2023-12-15 |
| IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies (NCT04153422) | Endeavor Health | 2023-12-15 |
| Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer (NCT06168552) | Zhejiang University | 2023-12-15 |
| ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin (NCT06521190) | Acousia Therapeutics GmbH | 2023-12-15 |
| A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy (NCT06255223) | Jinling Hospital, China | 2023-12-15 |
| A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma (NCT06152978) | Fudan University | 2023-12-15 |
| Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo (NCT05917561) | University Hospital, Bordeaux | 2023-12-15 |
| Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD (NCT06141876) | Apex Labs Ltd. | 2023-12-15 |
| A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis (NCT06218290) | Unicycive Therapeutics, Inc | 2023-12-15 |
| The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC Patients (NCT06174012) | Sun Yat-sen University | 2023-12-15 |
| Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients (NCT06003621) | Omico | 2023-12-15 |
| Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer (NCT05766371) | University of California, San Francisco | 2023-12-15 |
| A Study of YL202 in Selected Patients With Advanced Solid Tumors (NCT06107686) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2023-12-15 |
| The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence (NCT06166615) | Seoul National University Hospital | 2023-12-15 |
| Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients" (NCT06176339) | Mansoura University | 2023-12-15 |
| Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT03735589) | Roswell Park Cancer Institute | 2023-12-15 |
| Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity (NCT06140108) | SINA Health Education and Welfare Trust | 2023-12-15 |
| A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma (NCT06143579) | Sun Yat-sen University | 2023-12-15 |
| Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). (NCT05977907) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2023-12-14 |
| Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria (NCT06150924) | Mineralys Therapeutics Inc. | 2023-12-14 |
| Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy (NCT05560659) | Peter MacCallum Cancer Centre, Australia | 2023-12-14 |
| Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc (NCT06084338) | VA Office of Research and Development | 2023-12-14 |
| Definitive Radiation for High-Risk Spine Metastases (NCT06165419) | Stony Brook University | 2023-12-14 |
| The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites (NCT06433869) | Sun Yat-sen University | 2023-12-14 |
| A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (NCT06084884) | AstraZeneca | 2023-12-14 |
| Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC (NCT06137274) | H. Lee Moffitt Cancer Center and Research Institute | 2023-12-14 |
| This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. (NCT05946824) | University of Rochester | 2023-12-14 |
| PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma (NCT05922904) | M.D. Anderson Cancer Center | 2023-12-14 |
| Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma (NCT05286827) | National Cancer Institute (NCI) | 2023-12-14 |
| Goat or Cow Milk Based Infant Formula GMS (NCT06312059) | Kendal Nutricare Ltd | 2023-12-14 |
| AMPK-activation by Metformin in FSGS: AMP-FSGS (NCT06090227) | Yale University | 2023-12-14 |
| Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder (NCT05837104) | Mclean Hospital | 2023-12-13 |
| Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial (NCT05554367) | National Cancer Institute (NCI) | 2023-12-13 |
| A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria (NCT06295302) | Hubei Biological Medicine Industrial Technology Institute Co., Ltd. | 2023-12-13 |
| Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) (NCT06176196) | Vertex Pharmaceuticals Incorporated | 2023-12-13 |
| Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine (NCT06873282) | Research Institute of Influenza, Russia | 2023-12-13 |